• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE SENSOR; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 101967-750
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Pain (1994); Discomfort (2330); Swelling/ Edema (4577)
Event Date 10/23/2019
Event Type  Injury  
Event Description
On october 25, 2021, senseonics was made aware of an incident where patient complained of inflammation at insertion site.The site is warm, swollen, the patient has a "ball" feeling under the skin, there is no exudate, but there is a thickening with fluid and blood.He was initially prescribed the drug ibuprofen to relieve the pain and fight the inflammation at the sensor site.The patient states that he felt a growing sensation gradually from the time the sensor was implanted, but from (b)(6) 2021, pain, swelling and a "ball" of fluid under the skin appeared.The doctor confirmed severe inflammation and decided to remove the sensor.The patient also wanted the sensor removed due to severe discomfort in his arm.
 
Manufacturer Narrative
This report is being submitted retrospectively as part of an internal review.A review of the device's manufacturing records revealed that the sensor lot met all requirements including sterilization requirements for release.Based on the review of the manufacturing records, it can be concluded that there was no malfunction with the device.The sensor is inserted by making a small incision and placing it under skin and potential for developing skin irritation/swelling/pain/ inflammation/infection around the insertion site is a known anticipated adverse event.Patient visited the doctor who confirmed severe inflammation and decided to remove the sensor.Patient also wanted to have the sensor removed because of discomfort.However, patient mentioned that he would like to continue using the system and would purchase a new sensor.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE SENSOR
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20876 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20876-7005
MDR Report Key18435841
MDR Text Key331865645
Report Number3009862700-2023-00663
Device Sequence Number1
Product Code QCD
Combination Product (y/n)Y
Reporter Country CodePL
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 01/03/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date03/08/2022
Device Model Number101967-750
Device Catalogue NumberFG-4400-50-302
Device Lot NumberWP08438
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/10/2021
Initial Date FDA Received01/03/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-